Proteins, drug targets and the mechanisms they control: the simple truth about complex networks - PubMed (original) (raw)
Review
doi: 10.1038/nrd2381.
Affiliations
- PMID: 17932492
- DOI: 10.1038/nrd2381
Review
Proteins, drug targets and the mechanisms they control: the simple truth about complex networks
Robyn P Araujo et al. Nat Rev Drug Discov. 2007 Nov.
Abstract
Realizing the promise of molecularly targeted inhibitors for cancer therapy will require a new level of knowledge about how a drug target is wired into the control circuitry of a complex cellular network. Here we review general homeostatic principles of cellular networks that enable the cell to be resilient in the face of molecular perturbations, while at the same time being sensitive to subtle input signals. Insights into such mechanisms may facilitate the development of combination therapies that take advantage of the cellular control circuitry, with the aim of achieving higher efficacy at a lower drug dosage and with a reduced probability of drug-resistance development.
Similar articles
- Drug targets for tumorigenesis: insights from structural analysis of EGFR signaling network.
Durmuş Tekir S, Yalçin Arga K, Ulgen KO. Durmuş Tekir S, et al. J Biomed Inform. 2009 Apr;42(2):228-36. doi: 10.1016/j.jbi.2008.08.008. Epub 2008 Aug 26. J Biomed Inform. 2009. PMID: 18790083 - Molecular-targeted therapies: lessons from years of clinical development.
Rosa DD, Ismael G, Lago LD, Awada A. Rosa DD, et al. Cancer Treat Rev. 2008 Feb;34(1):61-80. doi: 10.1016/j.ctrv.2007.07.019. Epub 2007 Sep 10. Cancer Treat Rev. 2008. PMID: 17826917 Review. - Livin/ML-IAP as a new target for cancer treatment.
Liu B, Han M, Wen JK, Wang L. Liu B, et al. Cancer Lett. 2007 Jun 8;250(2):168-76. doi: 10.1016/j.canlet.2006.09.024. Epub 2007 Jan 10. Cancer Lett. 2007. PMID: 17218055 Review. - Rational targeting of Notch signaling in cancer.
Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rizzo P, et al. Oncogene. 2008 Sep 1;27(38):5124-31. doi: 10.1038/onc.2008.226. Oncogene. 2008. PMID: 18758481 Review. - [Molecular-targeted therapy for malignant glioma].
Yamanaka R. Yamanaka R. Brain Nerve. 2009 Feb;61(2):177-88. Brain Nerve. 2009. PMID: 19235468 Review. Japanese.
Cited by
- Utilizing the molecular gateway: the path to personalized cancer management.
Overdevest JB, Theodorescu D, Lee JK. Overdevest JB, et al. Clin Chem. 2009 Apr;55(4):684-97. doi: 10.1373/clinchem.2008.118554. Epub 2009 Feb 26. Clin Chem. 2009. PMID: 19246616 Free PMC article. Review. - High-order combination effects and biological robustness.
Lehár J, Krueger A, Zimmermann G, Borisy A. Lehár J, et al. Mol Syst Biol. 2008;4:215. doi: 10.1038/msb.2008.51. Epub 2008 Aug 5. Mol Syst Biol. 2008. PMID: 18682705 Free PMC article. - Molecular mechanisms of detection and discrimination of dynamic signals.
Antunes G, Roque AC, Simoes-de-Souza FM. Antunes G, et al. Sci Rep. 2018 Feb 6;8(1):2480. doi: 10.1038/s41598-018-20842-y. Sci Rep. 2018. PMID: 29410522 Free PMC article. - Protein-protein complexes can undermine ultrasensitivity-dependent biological adaptation.
Jeynes-Smith C, Araujo RP. Jeynes-Smith C, et al. J R Soc Interface. 2023 Jan;20(198):20220553. doi: 10.1098/rsif.2022.0553. Epub 2023 Jan 4. J R Soc Interface. 2023. PMID: 36596458 Free PMC article. - Screening drug target combinations in disease-related molecular networks.
Luo M, Jiao J, Wang R. Luo M, et al. BMC Bioinformatics. 2019 May 1;20(Suppl 7):198. doi: 10.1186/s12859-019-2730-8. BMC Bioinformatics. 2019. PMID: 31074386 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources